These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 36473671)

  • 21. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An
    Chaudhuri A
    J Mol Struct; 2021 Nov; 1243():130854. PubMed ID: 34121768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus.
    Bakhshandeh B; Jahanafrooz Z; Abbasi A; Goli MB; Sadeghi M; Mottaqi MS; Zamani M
    Microb Pathog; 2021 May; 154():104831. PubMed ID: 33727169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2: analysis of the effects of mutations in non-structural proteins.
    Senthilazhagan K; Sakthimani S; Kallanja D; Venkataraman S
    Arch Virol; 2023 Jun; 168(7):186. PubMed ID: 37344726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
    Liu J; Chen X; Liu Y; Lin J; Shen J; Zhang H; Yin J; Pu R; Ding Y; Cao G
    Infect Dis Poverty; 2021 Aug; 10(1):112. PubMed ID: 34419160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).
    Tyagi N; Sardar R; Gupta D
    PeerJ; 2022; 10():e13562. PubMed ID: 35765592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
    Vankadari N; Jeyasankar NN; Lopes WJ
    J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The First Geographic Identification by Country of Sustainable Mutations of SARS-COV2 Sequence Samples: Worldwide Natural Selection Trends.
    Mahmanzar M; Houseini ST; Rahimian K; Namini AM; Gholamzad A; Tokhanbigli S; Sisakht MM; Farhadi A; Kuehu DL; Deng Y
    bioRxiv; 2022 Jul; ():. PubMed ID: 35898341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses.
    Tohya Y; Narayanan K; Kamitani W; Huang C; Lokugamage K; Makino S
    J Virol; 2009 May; 83(10):5282-8. PubMed ID: 19264783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
    Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
    J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2.
    Wang Y; Kirkpatrick J; Lage SZ; Carlomagno T
    Structure; 2023 Feb; 31(2):128-137.e5. PubMed ID: 36610391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients.
    Shen M; Ding P; Luan G; Du T; Deng S
    Front Cell Infect Microbiol; 2023; 13():1141274. PubMed ID: 36960047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.
    Friedrich M; Pfeifer G; Binder S; Aigner A; Vollmer Barbosa P; Makert GR; Fertey J; Ulbert S; Bodem J; König EM; Geiger N; Schambach A; Schilling E; Buschmann T; Hauschildt S; Koehl U; Sewald K
    Front Bioeng Biotechnol; 2022; 10():801870. PubMed ID: 35309990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.